Emmaus Life Sciences, Inc.
EMMA
$0.01
$0.00-1.02%
OTC PK
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 19.91% | 17.08% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 19.91% | 17.08% | |||
| Cost of Revenue | 64.67% | -33.33% | |||
| Gross Profit | 17.40% | 22.28% | |||
| SG&A Expenses | -36.16% | -0.13% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -30.97% | -5.88% | |||
| Operating Income | 418.38% | 62.24% | |||
| Income Before Tax | 13.22% | 25.84% | |||
| Income Tax Expenses | 198.14% | -14,850.00% | |||
| Earnings from Continuing Operations | -82.91% | 51.29% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -82.91% | 51.29% | |||
| EBIT | 418.38% | 62.24% | |||
| EBITDA | 425.96% | 62.46% | |||
| EPS Basic | -82.58% | 51.23% | |||
| Normalized Basic EPS | 61.11% | 15.09% | |||
| EPS Diluted | -82.58% | 51.23% | |||
| Normalized Diluted EPS | 61.11% | 15.09% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||